Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis

Journal of Investigative Dermatology

Volumn 135, Issue 11, 2015, Pages 2824-2833

  Lewis, Julia M ^a   Bürgler, Christina D ^a   Freudzon, Marianna ^a   Golubets, Kseniya ^a   Gibson, Juliet F ^a   Filler, Renata B ^a   Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 6; LANGERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN P53; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADAPTIVE IMMUNITY; ALPHA BETA T LYMPHOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EPIDERMIS; FEMALE; GAMMA DELTA T LYMPHOCYTE; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; SKIN CARCINOGENESIS; SKIN CARCINOMA; T LYMPHOCYTE; TUMOR VOLUME; ULTRAVIOLET B RADIATION; UPREGULATION; ADVERSE EFFECTS; ANIMAL; CARCINOGENESIS; CELL CULTURE; DISEASE MODEL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INBRED MOUSE STRAIN; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; RADIATION RESPONSE; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

ANIMALS; BIOPSY, NEEDLE; CARCINOGENESIS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LANGERHANS CELLS; MICE; MICE, INBRED STRAINS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84947025057     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.207     Document Type: Article

References (45)

1. Aberer W, Romani N, Elbe A et al. (1986) Effects of physicochemical agents on murine epidermal Langerhans cells and Thy-1-positive dendritic epidermal cells. J Immunol 136:1210-6
2. Ahlfors H, Morrison PJ, Duarte JH et al. (2014) IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J Immunol 193:4602-13
3. Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517: 293-301
4. Bobr A, Igyarto BZ, Haley KM et al. (2012) Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration. Proc Natl Acad Sci USA 109:10492-7
5. Briso EM, Guinea-Viniegra J, Bakiri L et al. (2013) Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos. Genes Dev 27:1959-73
6. Chan KS, Carbajal S, Kiguchi K et al. (2004) Epidermal growth factor receptormediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 64:2382-9
7. Chang HR, Tsao DA, Wang SR et al. (2003) Expression of nitric oxide synthases in keratinocytes after UVB irradiation. Arch Dermatol Res 295:293-6
8. Chikama T, Liu CY, Meij JT et al. (2008) Excess FGF-7 in corneal epithelium causes corneal intraepithelial neoplasia in young mice and epithelium hyperplasia in adult mice. Am J Pathol 172:638-49
9. Daya-Grosjean L, Robert C, Drougard C et al. (1993) High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 53:1625-9
10. DiGiovanni J, Bol DK, Wilker E et al. (2000) Constitutive expression of insulinlike growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res 60:1561-70
11. Durinck S, Ho C,Wang NJ et al. (2011) Temporal dissection of tumorigenesis in primary cancers. Cancer Discov 1:137-43
12. Epstein JH (1983) Photocarcinogenesis, skin cancer, and aging. J Am Acad Dermatol 9:487-502
13. Eyerich S, Eyerich K, Pennino D et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119:3573-85
14. Fukunaga A, Khaskhely NM, Ma Y et al. (2010) Langerhans cells serve as immunoregulatory cells by activating NKT cells. J Immunol 185:4633-40
15. Girardi M, Oppenheim DE, Steele CR et al. (2001) Regulation of cutaneous malignancy by gammadelta T cells. Science 294:605-9
16. Girardi M, Glusac E, Filler RB et al. (2003) The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J Exp Med 198: 747-55
17. Henri S, Poulin L, Tamoutounour S et al. (2010) CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207:189-206
18. Ho KK, Halliday GM, Barnetson RS et al. (1991) Topical and oral retinoids protect Langerhans' cells and epidermal Thy-1+ dendritic cells from being depleted by ultraviolet radiation. Immunology 74:425-31
19. Jameson J, Ugarte K, Chen N et al. (2002) A role for skin γδ T cells in wound repair. Science 296:747-9
20. Kaplan DH, Jenison MC, Saeland S et al. (2005) Epidermal langerhans celldeficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-20
21. Kirchberger S, Royston DJ, Boulard O et al. (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210:917-31
22. Kripke ML (1984) Immunological unresponsiveness induced by ultraviolet radiation. Immunol Rev 80:87-102
23. Kubo A, Nagao K, Yokouchi M et al. (2009) External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206:2937-46
24. Kuo IH, Carpenter-Mendini A, Yoshida T et al. (2013) Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 133: 988-98
25. Kwong BY, Roberts SJ, Silberzahn T et al. (2010) Molecular analysis of tumorpromoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol 130:1726-36
26. Lewis JM, Bürgler CD, Fraser JA et al. (2014) Mechanisms of chemical cooperative carcinogenesis by epidermal langerhans cells. J Invest Dermatol 135:1405-14
27. Lim C, Savan R (2014) The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25:257-71
28. MacLeod AS, Rudolph R, Corriden R et al. (2014) Skin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair. J Immunol 192:5695-702
29. Merad M, Manz MG, Karsunky H et al. (2002) Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3: 1135-41
30. Modi BG, Neustadter J, Binda E et al. (2012) Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335:104-8
31. Nishibu A, Ward BR, Jester JV et al. (2006) Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J InvestDermatol 126: 787-96
32. Rabeony H, Petit-Paris I, Garnier J et al. (2014) Inhibition of keratinocyte differentiation by the synergistic effect of IL-17 A, IL-22, IL-1α, TNFα and oncostatin M. PLoS One 9:e101937
33. Rittié L, Varani J, Kang S et al. (2006) Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 126:732-9
34. Roediger B, Kyle R, Yip K et al. (2013) Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 14:564-73
35. Sandvik LF, Skarstein K, Sviland L et al. (2014) CD11c(+) dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients. Acta Derm Venereol 4:173-8
36. Seneschal J, Clark RA, Gehad A et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
37. Seré K, Baek JH, Ober-Blöbaum J et al. (2012) Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 37: 905-16
38. Shreedhar VK, Pride MW, Sun Y et al. (1998) Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 161: 1327-35
39. Shevchuk Z, Filip A, Shevchuk V et al. (2014) Number of Langerhans cells is decreased in premalignant keratosis and skin cancers. Exp Oncol 36: 34-7
40. Strid J, Roberts SJ, Filler RB et al. (2008) Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 9:146-54
41. Wakita D, Sumida K, Iwakura Y et al. (2010) Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol 40:1927-37
42. Wang L, Jameson SC, Hogquist KA (2009) Epidermal Langerhans cells are not required for UV-induced immunosuppression. J Immunol 183:5548-53
43. Yu SH, Bordeaux JS, Baron ED (2014) The immune system and skin cancer. Adv Exp Med Biol 810:182-91
44. Zhang W, Remenyik E, Zelterman D et al. (2001) Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 98:13948-53
45. Ziegler A, Jonason AS, Leffell DJ et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372:773-6